Opus Genetics (IRD) Common Equity (2010 - 2026)
Opus Genetics (IRD) reported Common Equity of -$12.99 million for Q2 2026, compared with $17.47 million a year earlier.
Powered by 
Analysis
Opus Genetics (IRD) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Opus Genetics posted Common Equity of $15.35 million, up 128.3% from FY2024.
- By year, Common Equity came in at $6.72 million in FY2024 (-86.5%), $49.91 million in FY2023 (+7.9%), $46.24 million in FY2022 (+108.1%) and $22.22 million in FY2021.
- Five-year quarterly Common Equity spans a low of -$45.84 million in Q1 2026 and a high of $50.28 million in Q3 2023.
- Year over year, Common Equity gained in 1 of the last six quarters, with an average decline of 36.4%.
- The high point for year-over-year Common Equity in five years was Q3 2023 (growth of 323.4%); the low point was Q1 2025 (a decline of 89.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$45.84 million (Q1 2026), $15.35 million (Q4 2025) and $5.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Opus Genetics | 417.37 Mn | 192.65 Mn | - | -12.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.99 Mn |
| Mar 31, 2026 | -45.84 Mn |
| Dec 31, 2025 | 15.35 Mn |
| Sep 30, 2025 | 5.97 Mn |
| Jun 30, 2025 | 17.47 Mn |
| Mar 31, 2025 | 5.07 Mn |
| Dec 31, 2024 | 6.72 Mn |
| Sep 30, 2024 | 34.30 Mn |
| Jun 30, 2024 | 40.64 Mn |
| Mar 31, 2024 | 46.06 Mn |
| Dec 31, 2023 | 49.91 Mn |
| Sep 30, 2023 | 50.28 Mn |
| Jun 30, 2023 | 37.70 Mn |
| Mar 31, 2023 | 41.25 Mn |
| Dec 31, 2022 | 46.24 Mn |
| Sep 30, 2022 | 11.88 Mn |
| Jun 30, 2022 | 14.60 Mn |
| Mar 31, 2022 | 17.27 Mn |
| Dec 31, 2021 | 22.22 Mn |
| Sep 30, 2021 | 20.57 Mn |
API Access
Opus Genetics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();